Literature DB >> 10022635

A reassessment of splenic hypofunction in celiac disease.

G R Corazza1, G Zoli, A Di Sabatino, R Ciccocioppo, G Gasbarrini.   

Abstract

OBJECTIVES: Because there is controversy regarding the prevalence, familial occurrence, and possible factors inducing splenic hypofunction in celiac disease, we have reassessed them in a large series of untreated patients and their first-degree relatives.
METHODS: Pitted red cell counting was used to measure splenic function and the effect that age at diagnosis has on it, while severity of intestinal lesions and nutritional status were estimated by multiple linear regression analysis. Moreover, serum tuftsin activity was assayed by measuring its ability to stimulate phagocytosis of opsonized Staphylococcus aureus.
RESULTS: We found that 32.8% of untreated celiacs and none of their relatives had pitted red cell values in the range of splenic hypofunction (>4%). Only age at diagnosis, but not the other two covariates, was significantly associated with the degree of splenic hypofunction. Tuftsin activity was depressed in celiac disease and this reduction was significantly greater in hyposplenic patients.
CONCLUSIONS: In celiac disease the prevalence of splenic hypofunction is lower than formerly believed. The duration of preexposure to gluten is a crucial factor for the prevalence and severity of this complication that does not affect celiac relatives. In celiac disease splenic hypofunction is accompanied by a reduced phagocyte activity linked to the decreased release of tuftsin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022635     DOI: 10.1111/j.1572-0241.1999.00865.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

Review 1.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 2.  Adult coeliac disease.

Authors:  Andrew D Hopper; Marios Hadjivassiliou; Sohail Butt; David S Sanders
Journal:  BMJ       Date:  2007-09-15

3.  Splenic volume differentiates complicated and non-complicated celiac disease.

Authors:  Tom van Gils; Petula Nijeboer; Jan Hein Tm van Waesberghe; Veerle Mh Coupé; Kiki Janssen; Jessy A Zegers; Shaikh A Nurmohamed; Georg Kraal; Sabine Ci Jiskoot; Gerd Bouma; Chris Jj Mulder
Journal:  United European Gastroenterol J       Date:  2016-08-17       Impact factor: 4.623

4.  Apoptosis and peripheral blood lymphocyte depletion in coeliac disease.

Authors:  A Di Sabatino; S D'Alò; D Millimaggi; R Ciccocioppo; R Parroni; G Sciarra; M G Cifone; G R Corazza
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

5.  Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome.

Authors:  F Trevisani; E Castelli; F G Foschi; M Parazza; E Loggi; M Bertelli; C Melotti; M Domenicali; G Zoli; M Bernardi
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Celiac disease diagnosis and management: a 46-year-old woman with anemia.

Authors:  Daniel Leffler
Journal:  JAMA       Date:  2011-10-12       Impact factor: 56.272

Review 7.  Is it worth investigating splenic function in patients with celiac disease?

Authors:  Antonio Di Sabatino; Laura Brunetti; Gabriella Carnevale Maffè; Paolo Giuffrida; Gino Roberto Corazza
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 8.  Thromboembolic complications and cardiovascular events associated with celiac disease.

Authors:  Fotios S Fousekis; Eleni T Beka; Ioannis V Mitselos; Haralampos Milionis; Dimitrios K Christodoulou
Journal:  Ir J Med Sci       Date:  2020-07-20       Impact factor: 1.568

Review 9.  Assessment of splenic function.

Authors:  A P N A de Porto; A J J Lammers; R J Bennink; I J M ten Berge; P Speelman; J B L Hoekstra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-19       Impact factor: 3.267

Review 10.  Celiac Disease: Extraintestinal Manifestations and Associated Conditions.

Authors:  Amelie Therrien; Ciaran P Kelly; Jocelyn A Silvester
Journal:  J Clin Gastroenterol       Date:  2020-01       Impact factor: 3.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.